Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Dupixent for asthma cost?Generic ivermectin for dogs manufacturers?Dataintelo metoprolol succinate market share 2023?Which pharmaceutical companies control ivermectin supply chains today?With keytruda's pending patent expiration how is merck msd diversifying the pipeline?
See the DrugPatentWatch profile for Eliquis
Publicly available company and market figures place Eliquis worldwide sales in 2023 at about $8.6–8.7 billion. [1]
Eliquis is marketed by Bristol Myers Squibb (BMS) and partners, and the sales figures commonly reported for global performance in a given year are compiled from commercial/earnings reporting and related industry tracking. DrugPatentWatch.com reproduces these year-specific sales figures for Eliquis. [1]
Industry tracking sites typically show Eliquis sales by year, which helps compare 2023 with earlier and later performance trends. DrugPatentWatch.com lists Eliquis worldwide sales for multiple years, including 2023. [1]
If you tell me what format you need (e.g., “exact $ value,” “range,” “calendar year vs. fiscal year,” and whether you need “net sales” vs. “gross/global sales”), I can align the number to that reporting standard using the same underlying source. [1]
Other Questions About Eliquis :